HCM
ABBV icon

Hodges Capital Management’s AbbVie ABBV Stock Holding History

Hodges Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.81M Sell
26,699
-5,148
-16% -$1.14M 0.48% 66
2025
Q4 		$7.28M Sell
31,847
-484
-1% -$110K 0.63% 57
2025
Q3 		$7.49M Sell
32,331
-247
-0.8% -$50.3K 0.64% 50
2025
Q2 		$6.05M Sell
32,578
-1,329
-4% -$247K 0.58% 59
2025
Q1 		$7.1M Sell
33,907
-7,082
-17% -$1.38M 0.71% 49
2024
Q4 		$7.28M Buy
40,989
+5,587
+16% +$1.03M 0.44% 72
2024
Q3 		$6.99M Sell
35,402
-200
-0.6% -$37.3K 0.45% 67
2024
Q2 		$6.11M Buy
35,602
+4,296
+14% +$712K 0.41% 81
2024
Q1 		$5.7M Sell
31,306
-8,742
-22% -$1.51M 0.36% 79
2023
Q4 		$6.21M Buy
40,048
+15,746
+65% +$2.3M 0.33% 86
2023
Q3 		$3.62M Sell
24,302
-10,405
-30% -$1.53M 0.43% 73
2023
Q2 		$5.68M Sell
34,707
-6,520
-16% -$956K 0.33% 81
2023
Q1 		$6.72M Sell
41,227
-846
-2% -$129K 0.55% 59
2022
Q4 		$6.8M Buy
42,073
+6,248
+17% +$958K 0.59% 58
2022
Q3 		$4.81M Sell
35,825
-8,313
-19% -$1.19M 0.79% 41
2022
Q2 		$6.76M Sell
44,138
-4,190
-9% -$640K 0.68% 47
2022
Q1 		$7.83M Sell
48,328
-9,915
-17% -$1.44M 0.62% 55
2021
Q4 		$7.89M Sell
58,243
-471
-0.8% -$55.6K 0.57% 63
2021
Q3 		$6.33M Buy
58,714
+6,186
+12% +$707K 0.47% 74
2021
Q2 		$5.92M Sell
52,528
-8,039
-13% -$905K 0.66% 53
2021
Q1 		$6.55M Sell
60,567
-284
-0.5% -$30.4K 0.91% 33
2020
Q4 		$6.52M Sell
60,851
-2,102
-3% -$202K 1.03% 29
2020
Q3 		$5.51M Buy
62,953
+5,897
+10% +$555K 1.07% 23
2020
Q2 		$5.6M Buy
57,056
+2,354
+4% +$207K 1.14% 23
2020
Q1 		$4.17M Sell
54,702
-3,792
-6% -$323K 1.07% 27
2019
Q4 		$5.24M Buy
58,494
+15,797
+37% +$1.31M 0.69% 45
2019
Q3 		$3.23M Buy
42,697
+8,931
+26% +$612K 0.37% 83
2019
Q2 		$2.46M Buy
33,766
+2,253
+7% +$177K 0.27% 91
2019
Q1 		$2.54M Sell
31,513
-2,979
-9% -$244K 0.26% 98
2018
Q4 		$3.18M Sell
34,492
-7,725
-18% -$679K 0.36% 70
2018
Q3 		$3.99M Buy
42,217
+477
+1% +$45.2K 0.29% 80
2018
Q2 		$3.87M Sell
41,740
-591
-1% -$57.7K 0.29% 85
2018
Q1 		$4.01M Buy
42,331
+5,806
+16% +$638K 0.32% 80
2017
Q4 		$3.53M Sell
36,525
-2,969
-8% -$280K 0.26% 84
2017
Q3 		$3.51M Sell
39,494
-12,464
-24% -$949K 0.24% 94
2017
Q2 		$3.77M Sell
51,958
-3,329
-6% -$224K 0.22% 94
2017
Q1 		$3.6M Sell
55,287
-1,058
-2% -$66.5K 0.18% 98
2016
Q4 		$3.53M Buy
56,345
+15,208
+37% +$928K 0.16% 110
2016
Q3 		$2.6M Buy
41,137
+4,404
+12% +$285K 0.12% 111
2016
Q2 		$2.27M Sell
36,733
-1,540
-4% -$93.8K 0.11% 117
2016
Q1 		$2.19M Buy
38,273
+2,253
+6% +$126K 0.1% 125
2015
Q4 		$2.13M Buy
36,020
+1,833
+5% +$106K 0.09% 128
2015
Q3 		$1.86M Buy
34,187
+4,652
+16% +$303K 0.08% 135
2015
Q2 		$1.98M Buy
29,535
+14,970
+103% +$977K 0.07% 145
2015
Q1 		$853K Buy
14,565
+339
+2% +$20.5K 0.03% 179
2014
Q4 		$931K Buy
14,226
+993
+8% +$62.6K 0.04% 173
2014
Q3 		$764K Sell
13,233
-296
-2% -$16.4K 0.03% 186
2014
Q2 		$764K Sell
13,529
-46
-0.3% -$2.41K 0.04% 175
2014
Q1 		$698K Buy
13,575
+488
+4% +$24.7K 0.04% 168
2013
Q4 		$691K Sell
13,087
-588
-4% -$28.9K 0.05% 159
2013
Q3 		$612K Sell
13,675
-1,300
-9% -$57.6K 0.05% 155
2013
Q2 		$619K Buy
+14,975
New +$655K 0.07% 151

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hodges Capital Management's ABBV Position: Q1 2026 in Review

Hodges Capital Management reduced its AbbVie (ABBV) stake by 16% in Q1 2026, selling an estimated $1.14M and leaving 26,699 shares worth $5.81M. The position accounts for 0.48% of the portfolio, ranked #66.

Hodges Capital Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.89M in Q4 2021. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Hodges Capital Management held 26,699 shares of AbbVie worth $5.81M as of Q1 2026.
  • Hodges Capital Management sold 5,148 AbbVie shares in Q1 2026, an estimated $1.14M.
  • AbbVie made up 0.48% of Hodges Capital Management's portfolio in Q1 2026, its #66 holding.
  • Hodges Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Hodges Capital Management's AbbVie position peaked at $7.89M in Q4 2021.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Hodges Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.